CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,724,648
- in 7 filings, $2.7M under 10b5-1 plans
Net −$2,724,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-09 | VIKING GLOBAL INVESTORS LP 10% owner | Purchase | +850,000 | $16.00 | $13.6M | 4,787,914 |
| 2023-05-02 | Kirn David Chief Executive Officer | Gift | −600,000 | 1,259,153 | ||
| 2023-05-02 | Kirn David Chief Executive Officer | Gift | +600,000 | 600,000 | ||
| 2023-04-21 | Bizily Scott Chief Legal and HR Officer | Option exercise 10b5-1 | +3,750 | $8.04 | $30K | 5,859 |
| 2023-04-21 | Bizily Scott Chief Legal and HR Officer | Sale 10b5-1 | −3,750 | $20.00 | $75K | 2,109 |
| 2023-04-21 | Bizily Scott Chief Legal and HR Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,750 | 52,500 | ||
| 2023-04-21 | Chacko Jacob Director | Option exercise 10b5-1 | +5,000 | $9.41 | $47K | 5,000 |
| 2023-04-21 | Chacko Jacob Director | Sale 10b5-1 | −5,000 | $20.05 | $100K | 0 |
| 2023-04-21 | Chacko Jacob Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 32,500 | ||
| 2023-03-01 | Bizily Scott Chief Legal and HR Officer | Option exercise | +1,875 | $6.49 | $12K | 4,357 |
| 2023-03-01 | Bizily Scott Chief Legal and HR Officer | Sale | −2,248 | $19.30 | $43K | 2,109 |
| 2023-03-01 | Bizily Scott Chief Legal and HR Officer | Option exercise · Stock Option (Right to Buy) | −1,875 | 20,250 | ||
| 2023-02-22 | Kirn David Chief Executive Officer | Sale | −16,449 | $20.22 | $333K | 1,859,153 |
| 2023-02-21 | Kirn David Chief Executive Officer | Sale | −17,090 | $20.93 | $358K | 1,876,509 |
| 2023-02-21 | Kirn David Chief Executive Officer | Sale | −907 | $21.49 | $19K | 1,875,602 |
| 2023-02-10 | Moretti August J Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-02-10 | Kirn David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +222,000 | 222,000 | ||
| 2023-02-10 | Kamal Fariborz President & COO | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2023-02-10 | Bizily Scott Chief Legal and HR Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-01-20 | Kirn David Chief Executive Officer | Sale | −8,625 | $20.19 | $174K | 1,893,599 |
Page 12 of 16 · 319 trades